Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2005

Published online before print October 21, 2004
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0704402v1
77/1/112    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwakkenbos, M. J.
Right arrow Articles by Hamann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwakkenbos, M. J.
Right arrow Articles by Hamann, J.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0704402


Received for publication July 15, 2004.
Revised September 14, 2004.
Accepted for publication September 23, 2004.


Article

Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells

Mark J. Kwakkenbos *, Walter Pouwels *, Mourad Matmati *, Martin Stacey {dagger}, Hsi-Hsien Lin {dagger}, Siamon Gordon {dagger}, René A. W. van Lier *, and Jörg Hamann *@

*Laboratory for Experimental Immunology, Academic Medical Centre, University of Amsterdam, The Netherlands; and {dagger}Sir William Dunn School of Pathology, University of Oxford, United Kingdom

@ To whom correspondence should be addressed. E-mail: j.hamann{at}amc.uva.nl.


   Abstract

The epidermal growth factor (EGF)-seven-span transmembrane receptors CD97 and EGF-like module-containing mucin-like receptor protein (EMR)2 are heptahelical molecules predominantly expressed on leukocytes. A characteristic of these receptors is their ability to interact with cellular ligands via the N-terminal EGF-like domains. The first two EGF domains of CD97 (but not EMR2) bind CD55 (decay-accelerating factor), and the fourth EGF domain of CD97 and EMR2 interacts with the glycosaminoglycan chondroitin sulfate (CS). Using fluorescent beads coated with soluble recombinant CD97 and EMR2 protein and isoform-specific monoclonal antibodies, we have determined the cellular and molecular characteristics of the interaction with CS. The fourth EGF domain of CD97 and EMR2 is expressed on activated lymphocytes and myeloid cells, whereas the ligand is specifically found on B cells within the peripheral blood. The interaction between CD97/EMR2 and CS may therefore play a role in the interaction of activated T cells, dendritic cells, and macrophages with B cells.

Key Words: B cell • EGF-like domain • ligand specificity • multivalent probe • proteoglycan




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Veninga, S. Becker, R. M. Hoek, M. Wobus, E. Wandel, J. van der Kaa, M. van der Valk, A. F. de Vos, H. Haase, B. Owens, et al.
Analysis of CD97 Expression and Manipulation: Antibody Treatment but Not Gene Targeting Curtails Granulocyte Migration
J. Immunol., November 1, 2008; 181(9): 6574 - 6583.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
M. van Pel, H. Hagoort, J. Hamann, and W. E. Fibbe
CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells
Haematologica, August 1, 2008; 93(8): 1137 - 1144.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Yona, H.-H. Lin, P. Dri, J. Q. Davies, R. P. G. Hayhoe, S. M. Lewis, S. E. M. Heinsbroek, K. A. Brown, M. Perretti, J. Hamann, et al.
Ligation of the adhesion-GPCR EMR2 regulates human neutrophil function
FASEB J, March 1, 2008; 22(3): 741 - 751.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. M. Abbott, I. Spendlove, P. Roversi, H. Fitzgibbon, V. Knott, P. Teriete, J. M. McDonnell, P. A. Handford, and S. M. Lea
Structural and Functional Characterization of a Novel T Cell Receptor Co-regulatory Protein Complex, CD97-CD55
J. Biol. Chem., July 27, 2007; 282(30): 22023 - 22032.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Matmati, W. Pouwels, R. van Bruggen, M. Jansen, R. M. Hoek, A. J. Verhoeven, and J. Hamann
The human EGF-TM7 receptor EMR3 is a marker for mature granulocytes
J. Leukoc. Biol., February 1, 2007; 81(2): 440 - 448.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. J. Kwakkenbos, M. Matmati, O. Madsen, W. Pouwels, Y. Wang, R. E. Bontrop, P. J. Heidt, R. M. Hoek, and J. Hamann
An unusual mode of concerted evolution of the EGF-TM7 receptor chimera EMR2
FASEB J, December 1, 2006; 20(14): 2582 - 2584.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the Society for Leukocyte Biology.